Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules

P. V. Adsule; D. V. Purandare; A. R. Chabukswar; R. Nanaware; P. D. Lokhande

doi:10.52711/0974-360X.2024.00156

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules

Author(s): P. V. Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande

Email(s): prajakta.adsule81@gmail.com

DOI: 10.52711/0974-360X.2024.00156

Address: P. V. Adsule1*, D. V. Purandare1, A. R. Chabukswar1, R. Nanaware1, P. D. Lokhande2
1School of Health Sciences and Technology, Department of Pharmaceutical Sciences, Dr. Vishwanath Karad MIT World Peace University, Pune – 411038.
2Department of Chemistry, Savitribai Phule Pune University, Pune 411007.
*Corresponding Author

Published In: Volume - 17, Issue - 3, Year - 2024

Keywords:

Cite this article:
P. V. Adsule, D. V. Purandare, A. R. Chabukswar, R. Nanaware, P. D. Lokhande. Designing of Coumarin molecules as EGFR inhibitors and their ADMET, MD Simulation Studies for Evaluating potential as Anticancer molecules. Research Journal of Pharmacy and Technology. 2024; 17(3):1008-4. doi: 10.52711/0974-360X.2024.00156

View PDF